Regional variations uncovered in the impact of dexamethasone treatment for severe COVID-19: Study
This study was conducted in Europe and India to examine the effects of giving patients injectable 12 mg versus 6 mg of…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
COVID-19 Updates
MHRA approves Pfizer/BioNTech’s adapted COVID-19 vaccine for Omicron XBB.1.5
The vaccine has been approved for use in individuals from six months of age
High levels of exposure to COVID virus may reduce protection from vaccination, prior infection:…
The study was performed to understand whether the immunity gained after vaccination or a prior infection was less effective or…
Biden administration to urge Americans get COVID-19 boosters
The official said that while the Centers for Disease Control and Prevention are reporting an increase in infections and hospital…
OCTAVE study reveals vaccine response in patients with impaired immune systems
Preliminary data from the OCTAVE study in August 2021 showed that a significant proportion of clinically at-risk patients with…
SII restarts manufacturing of COVISHIELD
Adar Poonawalla informs that the company already has six million booster doses of Covovax vaccine available and adults must take…
Study finds air pollution lowers Covid vaccine response
The results show that in uninfected individuals, pre-pandemic exposure to PM2.5, NO2 and black carbon was associated with a 5 to…
China approves its first mRNA vaccine from CSPC
The company said its independently developed mRNA vaccine SYS6006 targets some major Omicron variants and its booster dose showed…
IIT Madras researchers develop database on coronavirus antibodies
‘Ab-CoV’ can be a vital resource for researchers to develop therapeutic strategies against new variants of coronaviruses by…
SARS-CoV-2 Omicron XBB.1.5 variant is highly transmissible and infectious: Study
The XBB.1.5 S protein was also found to be highly resistant to neutralisation antibodies elicited by breakthrough infection with…